학술논문
Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine
human epidermal growth factor receptor 2
human epidermal growth factor receptor 2
Document Type
Report
Author
Source
Cancer Management and Research. Annual 2016, Vol. 8, p57, 9 p.
Subject
Language
English
ISSN
1179-1322
Abstract
The human epidermal growth factor receptor 2 (HER2) is overexpressed in 20% of breast carcinomas. Prior to the development of targeted therapies, HER2-positive breast cancer was associated with more aggressive [...]